As we age, there is a decrease in the number of neurons in the basal ganglia, cerebellum and spinal cord that can negatively ...
Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.
The ADAPT trial involves 70 refractory glaucoma patients, focusing on a 12-month primary effectiveness endpoint to evaluate the Calibreye TGT Surgical System. The Calibreye system is the first ...
The TikTok star, 37, was officially diagnosed with the terminal neurodegenerative disease in 2022 ...
The human eye may literally become a window revealing the earliest signals of Alzheimer's disease, thanks to a new federally funded research initiative at Oregon Health & Science University. The new ...
Digital innovation is reshaping ophthalmology, introducing new possibilities in diagnosis, monitoring, and care delivery. The field has witnessed major ...
An estimated 60% of patients with Alzheimer's disease develop epilepsy or subclinical epileptiform activity over the course of the disease. New-onset seizures in cognitively healthy adults also ...